Published in Regul Toxicol Pharmacol on May 22, 2008
First steps toward harmonized human biomonitoring in Europe: demonstration project to perform human biomonitoring on a European scale. Environ Health Perspect (2014) 1.24
Evaluation of biomonitoring data from the CDC National Exposure Report in a risk assessment context: perspectives across chemicals. Environ Health Perspect (2012) 1.04
Worrying exposure to trace elements in the population of Kinshasa, Democratic Republic of Congo (DRC). Int Arch Occup Environ Health (2012) 0.83
Blood biomonitoring of metals in subjects living near abandoned mining and active industrial areas. Environ Monit Assess (2012) 0.77
An evaluation of benchmark dose methodology for non-cancer continuous-data health effects in animals due to exposures to dioxin (TCDD). Regul Toxicol Pharmacol (2004) 1.72
Dioxin risks in perspective: past, present, and future. Regul Toxicol Pharmacol (2003) 1.61
Mortality rates among trichlorophenol workers with exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Am J Epidemiol (2009) 1.53
Renal function after reduction in cadmium exposure: an 8-year follow-up of residents in cadmium-polluted areas. Environ Health Perspect (2011) 1.39
Cadmium biomonitoring and renal dysfunction among a population environmentally exposed to cadmium from smelting in China (ChinaCad). Biometals (2002) 1.28
Prevalence of kidney dysfunction in humans - relationship to cadmium dose, metallothionein, immunological and metabolic factors. Biochimie (2009) 1.15
Plasma metallothionein antibody, urinary cadmium, and renal dysfunction in a Chinese type 2 diabetic population. Diabetes Care (2006) 1.15
Environmental epidemiological study and estimation of benchmark dose for renal dysfunction in a cadmium-polluted area in China. Biometals (2004) 1.08
Human response to dioxin: aryl hydrocarbon receptor (AhR) molecular structure, function, and dose-response data for enzyme induction indicate an impaired human AhR. J Toxicol Environ Health B Crit Rev (2006) 1.04
Non-renal effects and the risk assessment of environmental cadmium exposure. Environ Health Perspect (2014) 1.03
Cholinesterase inhibition in chlorpyrifos workers: Characterization of biomarkers of exposure and response in relation to urinary TCPy. J Expo Sci Environ Epidemiol (2008) 0.99
Thermal burn and electrical injuries among electric utility workers, 1995-2004. Burns (2006) 0.97
Variation in urinary flow rates according to demographic characteristics and body mass index in NHANES: potential confounding of associations between health outcomes and urinary biomarker concentrations. Environ Health Perspect (2015) 0.95
Environmental chemicals in people: challenges in interpreting biomonitoring information. J Environ Health (2008) 0.94
Public health interpretation of trihalomethane blood levels in the United States: NHANES 1999-2004. J Expo Sci Environ Epidemiol (2009) 0.94
Biomonitoring for occupational health risk assessment (BOHRA). Toxicol Lett (2009) 0.93
Human biomonitoring assessment values: approaches and data requirements. Int J Hyg Environ Health (2011) 0.92
Guidelines for the derivation of Biomonitoring Equivalents: report from the Biomonitoring Equivalents Expert Workshop. Regul Toxicol Pharmacol (2008) 0.91
Critical exposure level of cadmium for elevated urinary metallothionein--an occupational population study in China. Toxicol Appl Pharmacol (2006) 0.91
Guidelines for the communication of Biomonitoring Equivalents: report from the Biomonitoring Equivalents Expert Workshop. Regul Toxicol Pharmacol (2008) 0.91
Physiologically based pharmacokinetic modeling of arsenic in the mouse. J Toxicol Environ Health A (2004) 0.90
Recent developments in quantification methods for metallothionein. J Inorg Biochem (2002) 0.89
Kidney dysfunction and cadmium exposure--factors influencing dose-response relationships. J Trace Elem Med Biol (2012) 0.89
Hershey Medical Center Technical Workshop Report: optimizing the design and interpretation of epidemiologic studies for assessing neurodevelopmental effects from in utero chemical exposure. Neurotoxicology (2006) 0.88
Analysis of genomic dose-response information on arsenic to inform key events in a mode of action for carcinogenicity. Environ Mol Mutagen (2010) 0.88
Biomonitoring Equivalents for bisphenol A (BPA). Regul Toxicol Pharmacol (2010) 0.87
Perspective on serum dioxin levels in the United States: an evaluation of the NHANES data. J Expo Sci Environ Epidemiol (2008) 0.86
Separation of proteins including metallothionein in cerebrospinal fluid by size exclusion HPLC and determination of trace elements by HR-ICP-MS. Brain Res (2007) 0.86
Mortality in workers exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin at a trichlorophenol plant in New Zealand. J Occup Environ Med (2009) 0.86
A mechanism-based cancer risk assessment for 1,4-dichlorobenzene. Regul Toxicol Pharmacol (2007) 0.84
Estimation of benchmark dose for pancreatic damage in cadmium-exposed smelters. Toxicol Sci (2007) 0.83
Using Biomonitoring Equivalents to interpret human biomonitoring data in a public health risk context. J Appl Toxicol (2009) 0.83
Human biomonitoring as a pragmatic tool to support health risk management of chemicals--examples under the EU REACH programme. Regul Toxicol Pharmacol (2010) 0.82
Metal concentrations in cerebrospinal fluid and blood plasma from patients with amyotrophic lateral sclerosis. Biol Trace Elem Res (2012) 0.82
The Declaration of Brescia on Prevention of the Neurotoxicity of Metals Brescia, Italia 17-18 June 2006. Med Lav (2007) 0.81
The Declaration of Brescia on prevention of the neurotoxicity of metals June 18, 2006. Am J Ind Med (2007) 0.81
Metallothionein I isoform mRNA expression in peripheral lymphocytes as a biomarker for occupational cadmium exposure. Exp Biol Med (Maywood) (2009) 0.81
Hexavalent chromium reduction kinetics in rodent stomach contents. Chemosphere (2012) 0.81
Biomonitoring equivalents for di-isononyl phthalate (DINP). Regul Toxicol Pharmacol (2011) 0.81
Mortality rates among workers exposed to dioxins in the manufacture of pentachlorophenol. J Occup Environ Med (2009) 0.81
Biomonitoring Equivalents (BE) dossier for acrylamide (AA) (CAS No. 79-06-1). Regul Toxicol Pharmacol (2008) 0.81
Biomonitoring Equivalents for benzene. Regul Toxicol Pharmacol (2011) 0.80
Biomonitoring equivalents for inorganic arsenic. Regul Toxicol Pharmacol (2010) 0.80
Biomonitoring Equivalents for triclosan. Regul Toxicol Pharmacol (2010) 0.80
Toxicokinetics of 2,3,7,8-TCDF and 2,3,4,7,8-PeCDF in mink (Mustela vison) at ecologically relevant exposures. Toxicol Sci (2008) 0.80
Research toward the development of a biologically based dose response assessment for inorganic arsenic carcinogenicity: a progress report. Toxicol Appl Pharmacol (2007) 0.80
Biomonitoring equivalents for DDT/DDE. Regul Toxicol Pharmacol (2011) 0.80
Kinetics of arsenic methylation by freshly isolated B6C3F1 mouse hepatocytes. Chem Biol Interact (2006) 0.80
Manganese in cerebrospinal fluid and blood plasma of patients with amyotrophic lateral sclerosis. Exp Biol Med (Maywood) (2012) 0.80
Interpreting human biomonitoring data in a public health risk context using Biomonitoring Equivalents. Int J Hyg Environ Health (2011) 0.80
Is age an independent risk factor for chemically induced acute myelogenous leukemia in children? J Toxicol Environ Health B Crit Rev (2007) 0.80
Persistent organic pollutants in matched breast milk and infant faeces samples. Chemosphere (2015) 0.79
Tissue distribution of dioxin-like compounds: potential impacts on systemic relative potency estimates. Toxicol Lett (2013) 0.79
Evaluation of NHANES biomonitoring data for volatile organic chemicals in blood: application of chemical-specific screening criteria. J Expo Sci Environ Epidemiol (2011) 0.79
Relationship between mercury concentration in blood, cognitive performance, and blood pressure, in an elderly urban population. Biometals (2002) 0.79
Biomonitoring equivalents for 2,2',4,4',5-pentabromodiphenylether (PBDE-99). Regul Toxicol Pharmacol (2011) 0.79
Metallothionein gene expression in peripheral lymphocytes and renal dysfunction in a population environmentally exposed to cadmium. Toxicol Appl Pharmacol (2005) 0.78
Derivation of Biomonitoring Equivalents for cyfluthrin. Regul Toxicol Pharmacol (2009) 0.78
Metals in motor neuron diseases. Exp Biol Med (Maywood) (2006) 0.78
Estimates of cancer potency of 2,3,4,7,8-pentachlorodibenzofuran using both nonlinear and linear approaches. Toxicol Sci (2008) 0.78
Estimates of cancer potency of 2,3,7,8-tetrachlorodibenzo(p)dioxin using linear and nonlinear dose-response modeling and toxicokinetics. Toxicol Sci (2009) 0.78
Estimating uncertainty in observational studies of associations between continuous variables: example of methylmercury and neuropsychological testing in children. Epidemiol Perspect Innov (2007) 0.78
Increased hepatic and decreased urinary metallothionein in rats after cessation of oral cadmium exposure. Basic Clin Pharmacol Toxicol (2009) 0.77
Hepatic P450 enzyme activity, tissue morphology and histology of mink (Mustela vison) exposed to polychlorinated dibenzofurans. Arch Environ Contam Toxicol (2009) 0.77
Factors that distinguish serious versus less severe strain and sprain injuries: an analysis of electric utility workers. Am J Ind Med (2009) 0.77
Comparison of tissue dosimetry in the mouse following chronic exposure to arsenic compounds. J Toxicol Environ Health A (2005) 0.76
2,4-D exposure and risk assessment: comparison of external dose and biomonitoring based approaches. Regul Toxicol Pharmacol (2012) 0.76
Comment on "Chronic disease and early exposure to air-borne mixtures. 2. Exposure assessment". Environ Sci Technol (2008) 0.75
Development of screening tools for the interpretation of chemical biomonitoring data. J Toxicol (2012) 0.75
Case study for underground workers at an electric utility: how a research institution, university, and industry collaboration improved occupational health through ergonomics. J Occup Environ Hyg (2006) 0.75
Plasma metallothionein antibody and cadmium-induced renal dysfunction in an occupational population in China. Toxicol Sci (2005) 0.75
Occupational injury surveillance among electric utility employees. J Occup Environ Med (2004) 0.75
Obituary. Dr. Maths Berlin. Med Lav (2015) 0.75
Application of human biomonitoring (HBM) of chemical exposure in the characterisation of health risks under REACH. Int J Hyg Environ Health (2011) 0.75
Interpreting estrogen screening assays in the context of potency and human exposure relative to natural exposures to phytoestrogens. Birth Defects Res B Dev Reprod Toxicol (2014) 0.75
Relative cancer potencies of selected dioxin-like compounds on a body-burden basis: comparison to current toxic equivalency factors (TEFs). J Toxicol Environ Health A (2006) 0.75
The application of metallothionein (MT) gene expression in peripheral blood lymphocytes (PBLs) as a biomarker of cadmium exposure. Biometals (2004) 0.75
Nondestructive scat sampling in assessment of mink (Mustela vison) exposed to polychlorinated dibenzofurans (PCDFs). Arch Environ Contam Toxicol (2008) 0.75